Skip to main content

Table 1 Information on the studies included meta-analysis

From: The incubation period of COVID-19: a global meta-analysis of 53 studies and a Chinese observation study of 11 545 patients

Author

Country

Case number

Age, years

Gender

Incubation period, days

References

Ai et al

China

44

–

–

8.09 (SD: 4.99)

[40]

An et al

China

27

44

11M:16F

9.1 (R: 3–28)

[41]

Chen et al

China

19

–

–

5 (IQR: 3.3–10)

[42]

Chen et al

China

18

44.5

10M:8F

8 (IQR: 4–12)

[43]

Dai et al

China

180

NA

NA

4.95 (SD: 2.46)

[44]

Duan et al

China

42

51.48

15M:27F

7 (IQR: 2–13.5)

[45]

Fang et al

China

305

57

146M:159F

6 (R: 1–15)

[46]

Fu et al

China

24

38.92

14M:10F

5 (R: 0–35)

[47]

Han et al

China

226

44.4

97M:129F

7 (IQR: 5–11)

[48]

Jia et al

China

44

46

15M: 29F

6.28 (R: 1–14)

[49]

Jiang et al

China

43

50

15M:28F

5.95 (R: 2–13)

[50]

Jiang et al

China

17

–

6M:11F

7 (R: 1–14)

[51]

Jin et al. 1

China

21a

NA

NA

4 (IQR: 3–7)

[52]

  

195b

NA

NA

5 (IQR: 3–8)

 

Lai et al

China

330

47

161M:169F

7 (IQR:4–12)

[53]

Lai et al

China

40

NA

NA

4.2 (IQR: 4.0–4.5)

[54]

Li et al

China

47

35

23M:24F

9 (R: 1–20)

[55]

Li et al

China

30

32.57

30F

7.07 (SD: 4.08)

[56]

Li et al

China

86

–

–

6.3 (R: 1–12)

[57]

Li et al

China

51

–

–

5 (R: 2–10)

[58]

Liu et al

China

201

45.2

103M:98F

6.3 (R: 1–20)

[59]

Liu et al

China

87

NA

NA

10.4 (R:2–25)

[60]

Liu et al

China

41

42

19M:22F

8.8 (SD: 4.8)

[61]

Liu et al

China

44

–

–

8 (R: 1–19)

[62]

Liu et al

China

70

40

1.13

6 (R: 1–14)

[63]

Lu et al

China

100

37.13

52M:48F

11.14 (SD: 6.05)

[64]

Luo et al

China

24

35.3

14M:10F

8.5 (R: 1–14)

[65]

Ng et al

China

158

45

84M:74F

5.5 (SD: 3.26)

[66]

Ping et al

China

90

–

–

6.05 (IQR: 3.81–9.59)

[67]

She et al

China

991

43.96

1.16

5.2 (SD: 1.9)

[68]

Shen et al

China

10

60.5

6M:4F

4.5 (IQR: 2–6.5)

[69]

Tian et al

China

262

47.5

127M: 135F

6.7 (SD: 5.2)

[70]

Wang et al

China

483

NA

NA

7 (IQR: 4–11)

[71]

Wang et al

China

275

49

128M: 147F

6 (IQR: 3–9)

[72]

Wang et al

China

14

NA

NA

3 (IQR:2–5.25)

[73]

Wang et al

China

12

–

–

7.5 (IQR: 6–13.5)

[74]

Wu et al

China

41

38

19M:22F

6.05 (SD: 3.84)

[75]

Xia et al

China

10

56.5

6M: 4F

7 (SD: 2.59)

[76]

Yu et al

China

132

NA

172M: 161F

7.2 (IQR: 6.4–7.9)

[77]

Yuan et al

China

41

41

25M:16F

6.5 (IQR: 4.0–11.5)

[78]

Zhao et al

China

136

49

NA

6 (IQR: 4–11)

[79]

Zhang et al

China

353

–

–

5.9 (IQR: 3.8–8.6)

[80]

Zhong et al

China

48

41

31M: 17F

6.86 (SD: 3.57)

[81]

Zhu et al

China

245

–

–

6 (R: 1–23)

[82]

Chun et al

Korea

35

NA

NA

2.87 (SD: 1.64)

[3]

Viego et al

Argentina

15

NA

NA

7.86 (SD: 6.38)

[24]

Wong et al

Brunei

135

36

82/53F

5 (R: 1–11)

[25]

Pongpirul et al

Thailand

83

NA

NA

5 (IQR: 3–8)

[26]

Calba et al

France

10

NA

NA

4.5 (IQR: 2–7)

[27]

Laval et al

France

23

–

–

4 (R: 1–13)

[28]

Bui et al

Vietnam

19

NA

NA

6.4 (SD: 5.8)

[29]

Böhm et al

Germany

256

NA

NA

4.6 (SD: 3.0)

[30]

Patrikar et al

India

268

36.45

162M:106F

6.93 (SD: 5.87)

[32]

Tan et al

Singapore

164

44.2

77M:87F

5 (SD: 2.3)

[34]

  1. R, range; IQR, interquartile range; SD, standard deviation; M, male; F, female; NA, Not available
  2. aWith gastrointestinal symptom
  3. bWithout gastrointestinal symptom